Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.04
Schlusskurs vom Vortag:
$2.04
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.09M
KGV:
0.00
EPS:
-2.17
Netto-Cashflow:
$-16.92M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$21.96
Organovo Holdings Inc Stock (ONVO) Company Profile
Firmenname
Organovo Holdings Inc
Sektor
Branche
Telefon
858-224-1000
Adresse
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Vergleichen Sie ONVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONVO
Organovo Holdings Inc
|
0.00 | 3.10M | 0 | -19.09M | -16.92M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.84 | 25.49B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.71 | 110.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2256 | 38.69M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.14 | 59.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
69.79 | 5.64B | 0 | -153.72M | -103.81M | -2.00 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Eingeleitet | Raymond James | Outperform |
| 2015-08-11 | Herabstufung | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Eingeleitet | Jefferies | Buy |
| 2015-06-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Organovo Holdings Inc Aktie (ONVO) Neueste Nachrichten
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Organovo Holdings, Inc. Announces Board Appointments - marketscreener.com
Organovo Announces Close Of Sale Of FXR Program To Eli Lilly And Company - marketscreener.com
Organovo Holdings, Inc. and BICO Reach Licensing Agreement on Bioprinting Patents - marketscreener.com
VivoSim Labs introduces AI-driven drug testing models By Investing.com - Investing.com Canada
Organovo Holdings Rebrands to VivoSim Labs, Inc. - TipRanks
VivoSim Labs introduces AI-driven drug testing models - Investing.com Australia
FDA Shift Powers VivoSim's Game-Changing Drug Testing Tech: 50% Cost Reduction Target - Stock Titan
Organovo rebrands as VivoSim Labs, debuts new ticker By Investing.com - Investing.com South Africa
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' - GuruFocus
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' | ONVO Stock News - GuruFocus
Organovo rebrands as VivoSim Labs, debuts new ticker - Investing.com Australia
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting | ONVO Stock Ne - GuruFocus
Organovo Holdings Announces Transition to VivoSim Labs - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting - The Manila Times
Organovo Holdings, Inc. Announces Name Change to VivoSim Labs, Inc. and New Ticker Symbol "VIVS" - Nasdaq
Strategic Transformation: Organovo Becomes VivoSim Labs to Accelerate 3D Bioprinting Innovation - Stock Titan
StockNews.com Begins Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo stock plunges to 52-week low, touches $1.7 By Investing.com - Investing.com South Africa
Organovo (ONVO) Strengthens Position with FXR Program Sale - GuruFocus
Organovo (ONVO) Reports Preliminary Fiscal Year-End Cash Balance - GuruFocus
Organovo stock plunges to 52-week low, touches $1.7 - Investing.com Australia
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Eli Lilly and Company’s Acquisition of FXR Program from Organovo - Global Legal Chronicle
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organ On A Chip Market Generated Opportunities, Future Scope - openPR.com
Organovo (ONVO) Anticipates $5M Cash Influx as Nasdaq Compliance Continues - GuruFocus
Organovo reports $11.3M cash balance in FY24 - MSN
Organovo expects to maintain Nasdaq listing with stable stock price By Investing.com - Investing.com India
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - The Manila Times
Organovo Holdings Expects to Meet Nasdaq Listing Requirements - TipRanks
Organovo expects to maintain Nasdaq listing with stable stock price - Investing.com
Organovo stock plunges to 52-week low of $2.13 amid steep decline - Investing.com Canada
ONVO Stock Quote Price and Forecast - CNN
Organovo Holdings (ONVO) Sells FXR Program to Lilly (LLY), Secures Financial Future - GuruFocus
Organovo sells FXR Program, anticipates reduced costs By Investing.com - Investing.com South Africa
Organovo gets upfront payments following sale of its FXR Program to Lilly - Seeking Alpha
Organovo Provides Business Update - Quantisnow
Organovo sells FXR Program, anticipates reduced costs - Investing.com India
Organovo Holdings Completes Sale of FXR Program to Lilly - TipRanks
Finanzdaten der Organovo Holdings Inc-Aktie (ONVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.84%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):